The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/19607
StudyName: Eligibility Breast Cancer NCT00405938
Date of export from the portal: 02.07.2020
Date of Upload / last change: 15.01.2017
License: Creative Commons BY 4.0

----

Description: 
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00405938
